JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2011, Vol. 49 ›› Issue (2): 83-87.

• Articles • Previous Articles     Next Articles

Clinical characteristics and surgical treatment of pulmonary  sclerosing hemangioma

FANG Jian-wei1,  LIU Fan-ying1,  LI Jun1,2   

  1. 1. Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China;
    2. Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang 330029, China
  • Received:2010-10-27 Online:2011-02-10 Published:2011-02-10

Abstract:

Objective    To investigate the clinical characteristics, diagnosis and treatment of pulmonary sclerosing hemangioma (PSH) and to deepen the understanding of PSH. Methods    Clinical data from 18 patients with PSH, who underwent surgical resection in the Provincial Hospital Affiliated to Shandong University from April 2004 to March 2010, and the related literature were retrospectively reviewed. Results    Of the 18 patients with PSH confirmed by histopathology, 2 were males and 16 were females. The median age was 41.6 years, ranging from 18 to 56 years. 12 patients were detected by physical examination, while 4 patients presented with cough, 1 with cough and chest pain, and 1 with blood-stained sputum. The imaging examination generally revealed the peripherally solitary, well-circumscribed, and round or similarly round nodule with homogeneous density, and partly punctiform calcification. All these 18 patients received surgical resection without complications and mortality, 8 with lobectomy, 1 with wedge resection and 9  with tumor enucleation. No recurrence and no metastasis were detected during follow-ups. Conclusions    Clinical characteristics and imaging examinations of PSH are lack of specificity, and the accurate diagnosis depends on pathological examination. PSH should be suspected in middle-aged female patients with a peripherally solitary, well-circumscribed, and round or similarly round nodule of homogeneous density, whether the patients present symptoms or not. Surgical resection is effective for PSH.

Key words: Lung neoplasms; Sclerosing hemangioma; Diagnosis; Surgical treatment

CLC Number: 

  • R734.2
[1] XU Xiao-ya, BI Yu-li, JIANG Man, XU Ji-ying, ZHANG Peng-fei, HAN Ming-yong. Vascular endothelial growth factor (VEGF) promotes lung carcinoma metastasis via VEGFR1 in mouse model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 25-29.
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 108-110.
[3] TIAN Tian-tian1, LI Ji-sheng1, WANG Ya-wei1, MA Dao-xin2, WANG Xiu-wen1. Genistein exerts antitumor effects in small cell lung cancer H446 cells via suppressing the activity of FoxM1 pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(06): 44-48.
[4] LIU Bing1, YU Zhuang1, HOU Xian-peng1, YAO Ru-yong2. Different expressions of EGFR and HER-3 genes in human lung adenocarcinoma cells and pemetrexed-resistant cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 20-23.
[5] ALIMUJIANG·Stiwaerdi, ZHANG Tao, PATIGULI·Aerxiding, LIU Li. Clinical analysis of recombinant human endostatin combined with gemcitabine and  cisplatin therapy in advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 95-98.
[6] DONG Xue-li, MU Xiao-yan, LIU Qing-liang, SUN Jie. Effects of erlotinib combined with celecoxib on growth and angiogenesis of human lung cancer xenograft model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 49-52.
[7] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 130-131.
[8] LIU Qing-liang1, MU Xiao-yan1, WANG-Jing2, CHI Xiang-yu2, ZHANG Min3, MA Wei-xia3. Inhibitory effects of RNA interference and Erlotinib by blocking epidermal
growth factor receptor pathway on the proliferation of A549 cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 11-.
[9] FAN Heng-jian, ZHANG Yu-ke, XIAO Wei, ZHANG Yi, LI Hai-jun, WANG De-xiang. Changes of Treg and Th17 cells in the peripheral bloods of patients with
lung adenocarcinoma and their prognostic significance
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 73-78.
[10] WANG Ji-xia, LI Gui-xin, HUANG Yan, WANG Li-juan. Expressions and clinical significances of E1AF,MMP-7 and uPA in nonsmall cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 109-.
[11] XU Tong-zhen, SUN Xue-fei, REN Dong-mei, YANG Guo-tao. Antiproliferation activity of luteolin and its role in combined chemotherapy on lung cancer A549 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 50-54.
[12] LIU Hai-rong1, YU Jin-ming2, LI Yan1, LIANG Jing1, LIU Xiao-lin1. Study of the relationship between ER, PR, C-erB-2 and
bone metastasis of  lung adenocacinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(4): 91-.
[13] MA Yu-hua1,2, ZHENG Yan3, JIA Yan-fei3, WANG Yun-shan3. GFR and DEC1 protein co-expression promotes lymph node
metastasis in lung adenocarcinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 24-28.
[14] SUN Xue-fei, PEI Yan-tao,YIN Qiu-wei, YANG Guo-tao, WANG De-jiang. Inhibitory effect of Radix Actinidiae extractive on transplantation
tumor of the lung cancer cell line A549 in nude mice
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 38-42.
[15] LI Peng, LIU Qi, HAN Ming-yong. PET/CT,CEA and CYFRA21-1 predicting the therapeutic effect of targeted drug on non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 129-132.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!